Estimating the impact of differentiated models for HIV care

Lancet HIV. 2023 Oct;10(10):e628-e630. doi: 10.1016/S2352-3018(23)00225-4.

Authors

Mhairi Maskew¹, Sydney Rosen²

Affiliations

¹ Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2192, South Africa. Electronic address: [email protected].
² Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2192, South Africa; Boston University School of Public Health, Boston, MA, USA.

PMID: 37802565
DOI: 10.1016/S2352-3018(23)00225-4

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-HIV Agents* / therapeutic use
Delivery of Health Care
HIV Infections* / drug therapy
HIV Infections* / epidemiology
Humans

Substances

Anti-HIV Agents